Page results
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
Scientists and academics from UCL and UCLH have informed a new set of clinical guidelines to aid better diagnosis and management of endometriosis.
-
On Tuesday 22nd February 2022, the UCLH children and young people's diabetes team are holding a workshop, between 5-7pm on Zoom, for young people who are moving to adult services in 2022/2023, to share information about adult clinics.
-
The Carbs & Cals app is moving to a subscription-based service.
-
This Mobile Health Clinic has been extensively refurbished and fitted with a new digital portable x-ray camera and modern technologies to speed patient diagnoses and treatment of infectious diseases that will be powered on green energy.
-
A minimally invasive technique for treating prostate cancer has been used for the first time in the NHS at UCLH. It can be used with precision to treat the affected area, reducing side effects.
-
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.
File results
-
FOI/2024/0304 - Emergency medicine agency/ locum/ bank doctors January 2024-March 2024
-
FOI/2024/0330 - Off-framework agency spend/ staff contact details
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0469 - Total number of referrals to the Nursing and Midwifery Council 2019-2023
-
FOI/2024/0337 - IVF clinical unit/ embryology laboratory
-
FOI/2024/0341 - Robotic Process Automation (RPA)/ Intelligent Automation (IA) technology at Trust
-
FOI/2024/0352 - Bed occupancy all sites November 2023 to March 2024
-
FOI/2024/0481 - Holter monitor services
-
FOI/2024/0486 - Diagnostic tests for both point of care testing and laboratory
-
FOI/2024/0493 - Registered Allied Health Professionals (AHP) working in Trust - 2018 to 2024